September 2025
1. AHMED A, Chauhan A, Kumari A, Hokari R, et al
   Prevalence of Serologically Defined Celiac Disease in Patients With Irritable Bowel Syndrome in Asia: A Multicountry Hospital-Based Study.
   J Gastroenterol Hepatol. 2025 Sep 13. doi: 10.1111/jgh.70074.
   

   >> Share

   
   July 2025
2. YAN Y, Liu L, Shen XJ
   Comment on "Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome".
   J Gastroenterol Hepatol. 2025 Jul 23. doi: 10.1111/jgh.70032.
   

   >> Share

   
   
3. YAO Y, You X, Yang S, Xie Y, et al
   Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study.
   J Gastroenterol Hepatol. 2025 Jul 12. doi: 10.1111/jgh.70002.
   

   >> Share

   
   March 2025
4. CHENG L, Wang Q, Wu B, Yan X, et al
   Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial.
   J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16925.
   

   >> Share

   
   January 2025
5. LOO QY, Chuah KH, Hian WX, Khoo XH, et al
   Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
   J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1111/jgh.16891.
   

   >> Share

   
   
6. YU QX, Wang DD, Dong PJ, Zheng LH, et al
   Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis.
   J Gastroenterol Hepatol. 2025 Jan 8. doi: 10.1111/jgh.16858.
   

   >> Share

   
   December 2024
7. HISAKI Y, Sawada A, Kobayashi Y, Nishida Y, et al
   Epidemiology of Rome IV Fecal Incontinence in Japan: An Internet Survey of 9995 Individuals.
   J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1111/jgh.16838.
   

   >> Share

   
   November 2024
8. AGGARWAL N, Bhatia U, Dwarakanathan V, Singh AD, et al
   Prevalence and etiologies of non-responsive celiac disease: A systematic review and meta-analysis.
   J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16808.
   

   >> Share

   
   August 2024
9. GONG Q, Xiong F, Zheng Y, Guo Y, et al
   Tea-derived exosome-like nanoparticles prevent irritable bowel syndrome induced by water avoidance stress in rat model.
   J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16714.
   

   >> Share

   
   July 2024
10. WANG J, Sui WN, Zhao YQ, Meng SY, et al
    Genetic evidence for the causal impact of insomnia on gastrointestinal diseases and the mediating effects of adiposity traits.
    J Gastroenterol Hepatol. 2024 Jul 9. doi: 10.1111/jgh.16678.
    

    >> Share

    
    May 2024
11. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
    A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
    

    >> Share

    
    January 2024
12. CHUAH KH, Mahadeva S
    Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?
    J Gastroenterol Hepatol. 2024 Jan 18. doi: 10.1111/jgh.16487.
    

    >> Share

    
    November 2023
13. GHOSHAL UC, Mustafa U, Mukhopadhyay SK
    FODMAP meal challenge test: a novel investigation to predict response to low-FODMAP diet in non-constipating irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Nov 28. doi: 10.1111/jgh.16424.
    

    >> Share

    
    
14. KWAK N, Lee H, Kim BK, Yu YM, et al
    Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    J Gastroenterol Hepatol. 2023 Nov 13. doi: 10.1111/jgh.16406.
    

    >> Share

    
    September 2023
15. ZLOOF Y, Peretz L, Braun M, Simchoni M, et al
    Hypermobility spectrum disorders and irritable bowel syndrome: A nationwide study of 1.6 million adolescents.
    J Gastroenterol Hepatol. 2023 Sep 2. doi: 10.1111/jgh.16341.
    

    >> Share

    
    June 2023
16. FUTAGAMI S, Kessoku T, Kasai Y, Higurashi T, et al
    Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1111/jgh.16250.
    

    >> Share

    
    March 2023
17. OKUYAMA Y, Matsui D, Ozaki E, Watanabe Y, et al
    Association of low occlusal force as an oral hypofunction with the prevalence of irritable bowel syndrome in Japanese adults.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16175.
    

    >> Share

    
    
18. KHOO XH, Chong CW, Talha AM, Philip K, et al
    The impact of diet and ethnicity on Gut Microbiota Variation in Irritable Bowel Syndrome: A Multi-centre Study.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16174.
    

    >> Share

    
    
19. YASUDA R, Arai K, Kudo T, Nambu R, et al
    Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan.
    J Gastroenterol Hepatol. 2023 Mar 6. doi: 10.1111/jgh.16166.
    

    >> Share

    
    
20. DENG X, Xiao L, Luo M, Xie P, et al
    Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16159.
    

    >> Share

    
    December 2022
21. YANPING W, Gao X, Cheng Y, Liu M, et al
    The Interaction between Obesity and Visceral Hypersensitivity.
    J Gastroenterol Hepatol. 2022 Dec 7. doi: 10.1111/jgh.16083.
    

    >> Share

    
    November 2022
22. GWEE KA, Lee YY, Suzuki H, Ghoshal UC, et al
    Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms.
    J Gastroenterol Hepatol. 2022 Nov 1. doi: 10.1111/jgh.16046.
    

    >> Share

    
    August 2022
23. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    

    >> Share

    
    June 2022
24. ZHANG Y, Fu F, Zhang L, Zhang W, et al
    Telomere is Shortened in Patients with Irritable Bowel Syndrome in the Chinese Population.
    J Gastroenterol Hepatol. 2022 Jun 15. doi: 10.1111/jgh.15912.
    

    >> Share

    
    May 2022
25. BEK S, Teo YN, Tan XH, Fan KH, et al
    Association between Irritable Bowel Syndrome and Micronutrients: A Systematic Review.
    J Gastroenterol Hepatol. 2022 May 17. doi: 10.1111/jgh.15891.
    

    >> Share

    
    
26. ABUELAZM M, Abdelazeem B
    Vitamin D Supplementation for Irritable Bowel Syndrome: Concerns About the Meta-Analysis.
    J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15883.
    

    >> Share

    
    
27. UNO Y
    Paradigm shift in FODMAP theory.
    J Gastroenterol Hepatol. 2022;37:954.
    

    >> Share

    
    April 2022
28. CHONG RIH, Yaow CYL, Loh CYL, Teoh SE, et al
    Vitamin D Supplementation for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2022 Apr 8. doi: 10.1111/jgh.15852.
    

    >> Share

    
    
29. FAN K, Eslick GD, Nair PM, Burns GL, et al
    HUMAN INTESTINAL SPIROCHETOSIS, IRRITABLE BOWEL SYNDROME AND COLONIC POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Gastroenterol Hepatol. 2022 Apr 6. doi: 10.1111/jgh.15851.
    

    >> Share

    
    March 2022
30. ROTH B, Larsson E, Ohlsson B
    Poor intake of vitamins and minerals among patients with irritable bowel syndrome is associated with symptoms.
    J Gastroenterol Hepatol. 2022 Mar 18. doi: 10.1111/jgh.15830.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share